Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Children with alopecia areata, especially with Down syndrome or thyroid issues, should be screened for thyroid disease.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

An 11-year-old child with total hair loss may have a genetic autoimmune disease, and the outlook for hair regrowth is not good.

An infant with complete hair loss was diagnosed with a genetic disorder affecting hair growth.

A man with total hair loss developed blackhead-like spots on his scalp, possibly because no hair was present to help drain oils.

Chemotherapy for leukemia led to full hair regrowth in a child with alopecia totalis.

A 5-year-old boy with alopecia totalis had temporary hair regrowth with treatment but relapsed, highlighting the need for thorough investigation and holistic care.

A woman with alopecia totalis regrew dark hair in bands after using a corticosteroid ointment.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

A man with severe hair loss regrew all his hair using tofacitinib and stayed healthy for a year.

The patient's hair loss from alopecia totalis returned despite initial successful treatment.

Combining triamcinolone acetonide and immunotherapy can help regrow hair in some alopecia totalis patients.

Topical calcipotriol successfully treated hair loss in three patients with Alopecia Totalis.

Laser therapy might help regrow hair in alopecia totalis better than steroids alone.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Combining triamcinolone acetonide with immunotherapy can help regrow hair in some alopecia totalis patients.

Alopecia totalis/universalis is a severe form of hair loss where all body hair is lost.

Azathioprine can cause severe blood issues and hair loss, needing careful monitoring and possible discontinuation.

Botulinum toxin type A did not help regrow hair in severe alopecia cases.

Hair UpTM effectively and safely promotes hair regrowth, especially in minors.

A man with total hair loss also developed a rare nail condition, likely due to autoimmune issues.

Higher doses of prednisone and triamcinolone acetonide successfully treated 8 out of 10 alopecia totalis patients.

PRP did not significantly regrow hair in alopecia areata totalis patients.

Combining methotrexate with low-dose prednisone is more effective for hair regrowth in alopecia areata totalis.

The patient with total hair loss did not regrow hair despite treatment, indicating a poor outlook for this type of hair loss.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

The 2003 guidelines suggest that while some treatments can regrow hair in alopecia areata, none alter the disease's progression, and wigs may be the best option for extensive hair loss.